Development, stability and in vitro delivery profile of new loratadine-loaded nanoparticles.

Purpose: Loratadine is used as antihistaminic without side effects in nervous systems. This drug is a weak base and it is absorbed from the intestine. The nitrogen of the pyridine ring is protonated in the stomach affecting the oral bioavailability. The aim of this paper was obtaining, characterize and evaluate the release profiles and the stability of a gastroresistant loratadine nanosuspension. Methods: The nanosuspension was prepared by the solvent displacement evaporation method, using three different polymers (Eudragit® L 100 55, Kollicoat® MAE 100P and PEG 4000) and Polysorbate 80. Dynamic Light Scattering was used for evaluating the particle size (PS), zeta potential, and conductivity of the nanosuspension. Loratadine release profiles were evaluated in simulated gastrointestinal fluids. The shelf and accelerated stability were assessed during three months. Results: Nanosuspension particle size was 45.94 ± 0.50 nm, with a low polydispersion index (PdI, 0.300). Kollicoat® MAE 100P produced a hard and flexible coating layer. In simulated intestinal fluids, the 100 percent of loratadine was released in 40 min, while in simulated stomach fluids the release was lesser than 5%. Nanosuspension presented a good physicochemical stability showing a reduction in PS and PdI after three months (43.29 ± 0.16 and 0.250; respectively). Conclusions: A promissory loratadine nanosuspension for loratadine intestinal delivery was obtained, by using a low energy method, which is an advantage for a possible scale up for practical purpose.

NO-cGMP-K+ Channels Pathways Participate in the Antihypertensive Effects of Attalea phalerata Martius ex Spreng Oil-Loaded Nanocapsules.

Attalea phalerata Martius ex Spreng is a palm tree that is widely distributed in the Central-West region of Brazil. In this study, we investigated whether the oil-loaded nanocapsules of A. phalerata (APON) have acute and long-lasting antihypertensive effects in male spontaneously hypertensive rats (SHR), as well as explored the underlying molecular mechanisms. APON was prepared using the interfacial polymer deposition method. The particle size, polydispersity index, and zeta potential were investigated using dynamic and electrophoretic light scattering. The antihypertensive effects of APON (administered at doses of 1, 3, and 10 mg/kg) were evaluated after acute intraduodenal administration and after 7 days of oral treatment. To investigate the molecular pathways involved, we used pharmacological antagonists and inhibitors that target prostaglandin/cyclic adenosine monophosphate, nitric oxide/cyclic guanosine monophosphate, and potassium channels. Both acute and prolonged administration of APON (at doses of 3 and 10 mg/kg) resulted in a significant reduction in systolic, diastolic, and mean arterial pressure. Prior treatment with a non-selective nitric oxide synthase inhibitor (Nω-nitro-L-arginine methyl ester), guanylyl cyclase inhibitor (methylene blue), or non-selective calcium-sensitive K+ channel blocker (tetraethylammonium) abolished the antihypertensive effects of APON. Our study showed that A. phalerata oil-loaded nanocapsules have a significant antihypertensive effect in SHR after both short-term and long-term (7-day) use. This effect seems to rely on the vascular endothelium function and involves the NO-cGMP-K+ channel pathway. This research suggests a new direction for future studies to definitively prove the therapeutic benefits of APON in treating cardiovascular disease.

Immunomodulatory and Anticancer Effects of Fridericia chica Extract-Loaded Nanocapsules in Myeloid Leukemia.

Nanocapsules provide selective delivery and increase the bioavailability of bioactive compounds. In this study, we examined the anticancer and immunomodulatory potential of Fridericia chica (crajiru) extract encapsulated in nanocapsules targeting myeloid leukemias. Nanocapsules containing crajiru (nanocapsules-CRJ) were prepared via interfacial polymer deposition and solvent displacement. Size and polydispersity were measured by dynamic light scattering. Biological assays were performed on leukemia cell lines HL60 and K562 and on non-cancerous Vero cells and human PBMC. The anticancer activity was evaluated using cytotoxicity and clonogenic assays, while the immunomodulatory activity was evaluated by measuring the levels of pro- and anti-inflammatory cytokines in PBMC supernatants treated with concentrations of nanocapsules-CRJ. Nanocapsules-CRJ exhibited significant cytotoxic activity against HL60 and K562 cells at concentrations ranging from 0.75 to 50 µg/mL, with the greatest reductions in cell viability observed at 50 µg/mL (p < 0.001 for HL60; p < 0.01 for K562), while not affecting non-cancerous Vero cells and human PBMCs. At concentrations of 25 µg/mL and 50 µg/mL, nanocapsules-CRJ reduced the formation of HL60 and K562 colonies by more than 90% (p < 0.0001). Additionally, at a concentration of 12 µg/mL, nanocapsules-CRJ induced the production of the cytokines IL-6 (p = 0.0002), IL-10 (p = 0.0005), IL-12 (p = 0.001), and TNF-α (p = 0.005), indicating their immunomodulatory potential. These findings suggest that nanocapsules-CRJ hold promise as a potential therapeutic agent with both cytotoxic and immunomodulatory properties.

A Review of Pickering Emulsions: Perspectives and Applications.

Pickering emulsions are systems composed of two immiscible fluids stabilized by organic or inorganic solid particles. These solid particles of certain dimensions (micro- or nano-particles), and desired wettability, have been shown to be an alternative to conventional emulsifiers. The use of biodegradable and biocompatible stabilizers of natural origin, such as clay minerals, presents a promising future for the development of Pickering emulsions and, with this, they deliver some advantages, especially in the area of biomedicine. In this review, the effects and characteristics of microparticles in the preparation and properties of Pickering emulsions are presented. The objective of this review is to provide a theoretical basis for a broader type of emulsion, in addition to reviewing the main aspects related to the mechanisms and applications to promote its stability. Through this review, we highlight the use of this type of emulsion and its excellent properties as permeability promoters of solid particles, providing ideal results for local drug delivery and use in Pickering emulsions.

Anti-inflammatory effects and acute oral toxicity of Copaifera spp. essential oil-loaded nanoemulsion / Efectos antiinflamatorios y toxicidad oral aguda de nanoemulsión cargada de aceite esencial de Copaifera spp

Copaifera spp. essential oil (EOC) was extracted by hydrodistillation of Copaifera oleoresin (COR). The EOC was characterized by GC/MS and a novel EOC-loaded nanoemulsion was developed to enhance the EOC solubility and to evaluate its utility as antinflammatory. EOC contain 14 volatile compounds (including ß-caryophyllene: 51.52%) having a required HLB of 11. The Surfactant: EOC: Water ratio of 13:15:75 (%, w:w:w) produced the optimal formulation (particle size: 94.47 nm). The EOC-loaded nanoemulsion presented a pseudoplastic/thixotropic behavior with excellent shelf stability for 6 months. The anti-inflammatory effect of the nanoemulsion was more potent than that of the EOC, and statistically equal to diclofenac (50 mg/kg). The EOC-loaded nanoemulsion showed no oral acute toxicity (in mice) at 2000 mg/kg; hence, it is considered a nontoxic product. The development of the EOC-loaded nanoemulsion added value to both the COR and the EOC by providinga suitable formulation that could be used as an anti-inflammatory product.

El aceite esencial (EOC) fue extraído por hidrodestilación de oleoresina de Copaifera spp. El EOC fue caracterizado químicamente por GC/MS. Se formuló una nanoemulsión con EOC para mejorar la solubilidad del EOC y evaluar su utilidad como antiinflamatorio. El EOC contiene 14 compuestos volátiles (incluido el ß-cariofileno: 51,52%) con un HLB requerido de 11. La relación Tensioactivo: EOC: Agua de 13:15:75 (%, p:p:p) produjo la formulación óptima (tamaño de partícula: 94,47 nm).. La nanoemulsión cargada con EOC presentó un comportamiento pseudoplástico/tixotrópico con una excelente estabilidad en almacenamiento durante 6 meses. El efecto antiinflamatorio de la nanoemulsión fue más potente que el del EOC y estadísticamente igual al diclofenaco (50 mg/kg). La nanoemulsión cargada con COE no mostró toxicidad aguda oral (en ratones) a 2000 mg/kg; por lo tanto, se considera un producto no tóxico. El desarrollo de la nanoemulsión cargada con EOC agregó valor tanto al COR como al EOC al proporcionar una formulación adecuada que podría usarse como un producto antiinflamatorio.

Kollicoat MAE® 100P as a film former polymer for nanoparticles preparation / Kollicoat MAE® 100P como polímero formador de filme para a preparação de nanopartículas / Kollicoat MAE® 100P como polímero formador de película para la preparación de nanopartículas

SUMMARY Introduction: Until now, few research works have reported the usefulness of Kollicoat MAE® 100P as a film-former polymer for coating nanocapsules and as a matrix former for nanospheres. Aim: To update the current knowledge about the use of Kollicoat MAE® 100P as a film-former polymeric to prepare gastro-resistant nanoparticles. Physicochemical characteristics and functionality of nanoparticles coated with Kollicoat MAE® 100P were reported. Methodology: An exhaus tive review was performed (from 1980 to 2021) in various scientific databases like Medline, Scopus, EBSCO and Cambridge. Results: Kollicoat MAE® 100P is a versatile polymer that can be used to prepare gastro-resistant nanoparticles with actives of natural and synthetic origin. This polymer allows producing homogeneous nanoparticles with sizes smaller than 130 nm, and high z-potential, which confers a great stability to nanoparticle systems. On the other side, nanoparticles coated with Kollicoat MAE® 100P combined with plasticizer exhibit a hard and flexible shell, with excellent thermal stability up to 60 °C that dissolve at pH above 5.5. Conclu sion: Kollicoat MAE® 100P ris a viable, low-cost, and multifunctional alternative for nanoparticle preparation, however, more studies are needed to develop enhanced nanoparticles with better performances.

RESUMO Introdução: até hoje, poucas pesquisas têm sido desenvolvidas com o intuito de avaliar a utilidade do Kollicoat MAE® 100P como polímero formador de filme para recobrimento de nanocápsulas e como formador de matriz para preparação de nanoesferas. Objetivo: atualizar o estado da arte sobre a utilização de Kollicoat MAE® 100P para a preparação de nanopartículas gastrorresistentes, suas caracterís ticas físico-químicas e a funcionalidade das nanopartículas cobertas com Kollicoat MAE® 100P. Metodologia: foi realizada uma revisão exaustiva (de 1980 a 2021) em várias bases de dados como Medline, Scopus, EBSCO e Cambridge. Resul tados: Kollicoat MAE® 100P é um polímero versátil, que pode ser utilizado para a preparação de nanopartículas gastrorresistentes carregadas com ativos naturais e sintéticos, com tamanho menor que 130 nm, baja polidispersão e alto potencial z, o que lhe confere grande estabilidade. O Kollicoat MAE® 100P combinadas com plastificantes adequados, produze cobertas duras e flexíveis, com excelente estabili dade térmica até 60 °C, que dissolvem em pH acima de 5,5. Conclusões: Kollicoat MAE® 100P representa uma alternativa viável, de baixo custo e multifuncional para a preparação de nanocápsulas e nanoesferas gastroresistentes. No entanto, outros estudos são necessários para desenvolver nanoformulações baseadas neste polímero com melhor funcionalidade.

RESUMEN Introducción: hasta ahora, pocos trabajos de investigaciones han relatado la utilidad de Kollicoat MAE® 100P como polímero formador de película para el recubrimiento de nanocápsulas y como formador de matriz para preparar nanoesferas. Objetivo: actualizar el estado del conocimiento sobre las características fisicoquímicas de Kollicoat MAE® 100P, su uso como material formador de películas de cubierta para preparación de nanopartículas gastrorresistentes, y la funcionalidad de las nanopartículas preparadas con este polímero. Metodología: se realizó una revisión exhaus tiva (de 1980 a 2021) en varias bases de datos como Medline, Scopus, EBSCO y Cambridge. Resultados: Kollicoat MAE® 100P es un polímero versátil que puede utilizarse para la preparación de nanopartículas gastrorresistentes usando activos naturales y sintéticos. Este polímero produce nanopartículas menores que 130 nm, bajo índice de polidispersión y potencial z relativamente altos, lo que confiere gran estabilidad a formulaciones de nanopartículas. El Kollicoat MAE® 100P, combinado con un plastificante adecuado, produce una cubierta dura y flexible, con excelente estabilidad térmica a temperaturas hasta 60 °C que se disuelve a pH mayores que 5,5. Conclusión: Kollicoat MAE® 100P es un polímero multifuncional, de bajo costo útil para preparar nanopartículas gastroresistentes. Sin embargo, podrían realizarse otros estudios para desarrollar nanopartículas con mejor funcionalidad.

Spray dried extract of Calophyllum brasiliense Cambés produces a potent hypoglycemic effect and improves total serum cholesterol and triglycerides in diabetic rats / El extracto secado por pulverización de Calophyllum brasiliense cambés produce un potente efecto hipoglucémico y mejora el colesterol sérico total y los triglicéridos en ratas diabéticas / O extrato seco por aspersão de Calophyllum brasiliense Cambés produz um potente efeito hipoglicemiante e melhora o colesterol total e triglicérideos em ratos diabéticos

SUMMARY Introduction: The species Calophyllum brasiliense Cambés (Calophyllaceae) is widespread throughout Central and South America. The stem bark infusion is used for lowering blood glucose. Aim: To optimize the spray dry extract ofthis plant using a D-optimal experimental design. Materials and methods: As factors were used the air-drying speed (3.5-4.5 m3/h), the feed flow rate of the suspension (5-11 mL/ min), and the inlet air temperature (90-130 °C). The dried extract was characterized by measuring the phenolics and flavonoids content, moisture, the water activity, apparent densities, flowability, and compressibility. The antioxidant activity, the inhibitory activity of lipase and alpha-glycosidase, and the antiglycant activity of the spray dried extract (SDE) were evaluated. Subsequently, the hypoglycemic activity was evaluated in rats by monitoring the blood glucose level, triglycerides, and cholesterol. Results: Inlet air temperature and feed flow rate were the factors that most affected the yield and phenolic content. SDE showed a potent antioxidant effect (IC50 1.83 μg/mL), a potent a-glycosidase (IC50 74.45 μg/mL) and pancreatic lipase (IC50 27.33 μg/mL) inhibition. A potent antiglycation effect (IC50 9.45^g/mL) was also observed. Conclusion: the SDE showed a potent hypoglycemic effect at 100 mg/kg. These results suggest that SDE could activate four important pathways that can contribute to diabetes control.

Resumen Introducción: la especie Calophyllum brasiliense (Calophyllaceae) está muy extendida en Centro y Suramérica. La infusión del tronco reduce los niveles de glucosa en sangre. bjetivo: optimizar el extracto seco por aspersión (SDE) de esta planta utilizando un diseño experimental D-óptimal. Materiales y métodos: como factores se utilizaron la velocidad del gas secante (aire, 3,5-4,5 m3/h), la temperatura de entrada del aire fue 90-130 °C y la velocidad de alimentación, 5-11 mL/min. Se determinó el contenido de fenoles y flavonoides en el extracto seco, la humedad residual, la actividad del agua, las densidades aparentes, fluidez y compresibilidad. Se evaluó la actividad antioxidante e inhibidora de lipasa y alfa-glicosidasa y la actividad antiglicante. También se evaluó la actividad hipoglicemiante midiendo glucosa en sangre, triglicéridos y colesterol. Resultados: la temperatura del aire de entrada y la velocidad de alimentación afectaron, significativamente, el rendimiento y contenido de fenoles. El SDE mostró un potente efecto antioxidante (IC50 1,83 μg/mL), una potente inhibición de a-glicosidasa (IC50 74,45 μg/mL) y de lipasa pancreática (IC50 27,33 μg/ mL). Se observó un fuerte efecto antiglicante (IC50 9,45 μg/mL). Conclusiones: el SDE mostró un potente efecto hipoglicemiante a 100 mg/kg. Estos resultados sugieren que el SDE podría actuar activando cuatro vías importantes para el control de la diabetes.

RESUMO Introdução: a espécie Calophyllum brasiliense (Calophyllaceae) é amplamente distribuída na América do Sul e Central. A infusão da casca do caule reduz os níveis de glicose no sangue. Objetivo: otimizar o extrato seco por pulverização (SDE) desta planta usando um planejamento experimental D-ótimo. Materiais e métodos: a velocidade do gás de secagem ar (3,5-4,5 m3/h), a temperatura de entrada do ar (90-130 °C) e a taxa de alimentação (5-11 mL/min) foram usados como fatores. Foi determinado o teor de fenóis e flavonóides no extrato seco, a umidade residual, a atividade de água, as densidades aparentes, a fluidez e a compressibilidade. Avaliou-se a atividade antioxidante e a atividade inibitória de lipase e alfa-glicosidase, e a atividade antiglicante do extrato seco. A atividade hipoglicêmica foi avaliada em ratos diabeticos, medindo a glicose no sangue, triglicerídeos e colesterol. Resultados: a temperatura de entrada do ar e a taxa de alimentação afetaram significativamente o desempenho e o conteúdo de fenois. O SDE mostrou um potente efeito antioxidante (IC50 1,83 μg/mL), uma significativa inibição de a-glicosidase (IC50 74,45 ig/mL) e da lipase pancreática (IC50 27,33 μg/mL). Um forte efeito antiglicante também foi observado (IC50 9,45 μg/mL). O SDE mostrou um forte efeito hipogli-cemiente à concentração de 100 mg/kg. Conclusões: Esses resultados sugerem que o SDE poderia atuar ativando quatro vias importantes para o controle do diabetes.

Antioxidant and Hepatoprotective Activity of a New Tablets Formulation from Tamarindus indica L.

Hepatotoxic chemicals damage liver cells primarily by producing reactive oxygen species. The decoction of the leaves of Tamarindus indica L. is used for liver disorders. In this work we evaluated the hepatoprotective activity of a tablet formulation of this plant. Thirty-five Sprague Dawley rats were randomly divided into five groups (n = 7). First group (I) is control group, fed with standard diet. Groups II to V (hepatotoxic groups) were subjected to a subcutaneous injection of CCl4 (0.5 mL/kg). Group II was negative control, fed with standard diet; group III was subjected to administration of Silymarin 150 mg/kg and groups IV and V were treated with tablets in dose of 100 mg/kg and 200 mg/kg, respectively. Lipid peroxidation and the activity of superoxide dismutase, catalase, and reduced glutathione were evaluated. Serum levels of alanine aminotransferase, aspartate aminotransferase, gamma-glutamine transferase, alkaline phosphatase, and a lipid profile were evaluated too. The tablets inhibit lipid peroxidation. The redox balance (SOD-CAT-GSH) remains normal in the experimental groups treated with tablets. The liver function using dose of 200 mg/kg of tablets was better than the other experimental groups. These results justify, scientifically, the ethnobotanical use of the leaves of Tamarindus indica L.

Validación del método de determinación de flavonoides en tabletas de Passiflora incarnata L / Validation of flavonoid quantification method in Passiflora incarnata L. tablets

OBJETIVO: validar el método de cuantificación de flavonoides en las tabletas de Passiflora incarnata L., utilizando como patrón quercetina. MÉTODOS: se evaluó la especificidad, linealidad, exactitud, precisión y robustez según las recomendaciones de la USP 30 y el Centro para el Control Estatal de la Calidad de los Medicamentos (CECMED). RESULTADOS: en las condiciones practicadas en este trabajo el método es selectivo; resultó lineal en un rango de 60 a 140 por ciento de concentración de flavonoides. Mostró exactitud y precisión con coeficiente de variación global de 0,67 por ciento. No varió significativamente cuando se modificaron las condiciones de análisis. CONCLUSIONES: el método analítico, en las condiciones practicadas, es fiable y permite obtener resultados apropiados para el uso que se pretende(AU)

INTRODUCTION: to validate the flavonoid quantification method on Passiflora incarnata L. tablets by using quercetine as standard. METHODS: selectivity, linearity, accuracy, precision and robustness were evaluated, using USP 30 and the regulations of the Center for the State Control of Drug Quality (CECMED). RESULTS: under the conditions of this study, the method is selective, linear in a range of 60 to 140 percent of flavonoid concentration. It showed accuracy and precision with global relative standard deviation of 0.67 percent. The results did not significantly vary when the analytical conditions changed. CONCLUSIONS: under the established conditions, this method is reliable and allows obtaining appropriate results for the intended use(AU).

Formulación de cápsulas duras de Tamarindus indica L / Formulation of hard capsules from Tamarindus indica L

OBJETIVO: formular cápsulas duras a partir de extracto blando de Tamarindus indica L. MÉTODOS: se seleccionaron las cantidades de los excipientes lactosa monohidratada, almidón de maíz y dióxido de silicio coloidal (Aerosil®), utilizando un diseño factorial 23. Se seleccionó para envasar en cápsulas, el granulado con mejor fluidez y menor humedad residual. Se evaluó la calidad de las cápsulas duras. RESULTADOS: la formulación escogida fue lactosa monohidratada 35,0 g, Aerosil® 3,0 g y almidón de maíz 7,5 g, pues mostró buena fluidez y una humedad residual de 4,17 por ciento. Las cápsulas duras formuladas, presentaron buena calidad tecnológica. CONCLUSIONES: se obtuvieron cápsulas duras que pueden ser preparadas, a pequeña escala, a nivel dispensarial(AU)

OBJECTIVE: to formulate hard capsules from Tamarindus indica L. soft extract. METHODS: the amounst of the exicipients called lactose monohydrate, corn starch and colloidal silicon dioxide (Aerosil®) were selected, using a 23 full factorial design. The selection of the best formulation was based on the best rheological properties and the least residual humidity. The quality of the filled hard capsules was evaluated. RESULTS: the formulation containing lactose monohydrate 35.0 g, Aerosil® 3.0 g and corn starch 7.5 g was selected. This formulation showed good fluidity and 4.17 percent residual humidity. Hard capsules showed good technological quality. CONCLUSIONS: hard capsules that can be prepared at small-scale production dispensaries(AU)

State of the art in Cassia grandis L. f. (cañandonga) / Estado del arte sobre Cassia grandis L. f. (cañandonga)

INTRODUCTION: the species Cassia grandis L. f. (cañandonga) is recognized by the Cuban Health System and the population for its antianemic properties, in spite of the unpleasant odor of its fruit. OBJECTIVES: to perform a bibliographic update about the chemical, toxicological and pharmacologic characteristics of the study species. METHODS: an extensive review was conducted in international databases such as HighWire, DOAJ, EBSCO, Scielo, Scopus, Chemical Abstract, Medline, PudMed, and Pharmaceutical Abstract, in addition to the national database CuMed from the year 1900 until 2012. RESULTS: there are still not enough studies that certify its usefulness and pharmaco-toxicological safety as antianemic, and few pharmaceutical formulations have been developed. The fruit is the most studied organ of the species. CONCLUSIONS: it is necessary to carry out new investigations to certify its antianemic effect and develop new therapeutic alternatives to eliminate the unpleasant odor of Cassia grandis L. f. fruit formulations.

INTRODUCCIÓN: la especie Cassia grandis L. f. (cañandonga) es reconocida en el sistema de salud cubano y su población por sus propiedades antianémicas, a pesar del desagradable olor de sus frutos. OBJETIVO: evaluar el estado del arte sobre aspectos químicos, toxicológicos y farmacológicos de Cassia grandis L. f. (cañandonga) desde 1900 hasta 2012. MÉTODOS: se revisó en bases de datos internacionales como HighWire, DOAJ, EBSCO, Scielo, Scopus, Chemical, Abstract, Medline, PudMed, y Pharmaceutical Abstract, además de la base de datos nacional CuMed desde 1900 hasta 2012. RESULTADOS: aún son insuficientes los estudios que avalan su utilidad y seguridad farmacotoxicológica como antianémico, así como pocas las formulaciones farmacéuticas desarrolladas. El fruto es el órgano más estudiado de la especie. CONCLUSIONES: se necesita realizar nuevas investigaciones para avalar su efecto antianémico y de otras alternativas terapéuticas que permitan eliminar el olor desagradable de las preparaciones de los frutos de esta planta.

Desempeño analítico de los métodos de control de calidad de una solución concentrada para hemodiálisis / Analytical performance of the quality control methods in a concentrated solution for hemodialysis

Objetivo: evaluar el desempeño de los métodos de cuantificación de los iones sodio, potasio, cloruro, calcio y magnesio en una solución concentrada para hemodiálisis con bicarbonato. Métodos: los cinco métodos aparecen informados en la farmacopea británica. Para la verificación del desempeño, se utilizaron los parámetros, linealidad, exactitud y precisión. Se empleó el método de placebo enriquecido utilizando niveles de 60 a 140 por ciento de la concentración nominal de cada ion. Resultados: los cinco métodos resultaron lineales en el intervalo de concentraciones evaluadas, fueron precisos y exactos, con coeficientes de variación global menor que 1,75 por ciento, y una recuperación entre 100 ± 3 por ciento. Conclusiones: los métodos de cuantificación de los iones presentes en la solución concentrada para hemodiálisis con bicarbonato, permiten obtener resultados fiables en las condiciones analíticas practicadas en esta investigación(AU)

Objective: to evaluate the analytical performance of the sodium, potassium, chloride, calcium and magnesium ions quantification methods, in a concentrated solution with bicarbonate for hemodyalisis. Methods: the five analytical methods are reported on the official British pharmacopeia. The performance evaluation was made by verifying linearity, accuracy and precision. In all cases, the enriched placebo method was used, with concentration levels from 60 to 140 percent of the standard concentration value of each ion. Results: the five methods showed linearity in the evaluated concentration range; they were accurate and precise with global variation coefficients lower than 1.75 percent, and a recovery rate of 100 ± 3 percent. Conclusions: the quantification methods for the ions present in concentrated solution with bicarbonate for hemodialysis, allows obtaining reliable results under the analytical conditions used in this research(AU)

Toxicidad aguda oral e irritabilidad de la mucosa oral con una formulación de tabletas de Tamarindus indica L / Acute oral toxicity and irritability of the oral mucosa with a tablet formulation of Tamarindus indica L

In this study, the possible preclinical toxic effects of the Tamarindus indica L tablets were evaluated by the acute oral toxicity (AOT) and oral mucosa irritation (OMI), adapting guideline OECD 423 and ISO 10993-10, respectively. The AOT was evaluated, using the Class Toxocity Method in Sprague Dawley females rats and the OMI was assessed in sirian hamsters, according to the acute exposure method. Any sign of toxicity were not observed in the study. No animal death was occurring and the body weight increase in the two experimental groups was not statistically different. Slight irritation of the oral mucosa of the animals was observed, but this fact didn't impede them to feed appropriately and they body weight increase normally during the assay. Tamarind tablets were framed as non toxic substance and they produce a “light irritability” of the oral mucosa.

En este trabajo se evaluó a nivel preclínico, los posibles efectos tóxicos de las tabletas de Tamarindus indica L. Se ensayó la toxicidad aguda oral, por el método de las clases de toxicidad, en ratas hembras de la línea Sprague Dawley y la irritabilidad de la mucosa oral en Hamster sirio, según las normas OECD 423 y ISO 10993-10, respectivamente. Durante el estudio de toxicidad aguda, no se observaron signos de toxicidad, ni muerte. El peso corporal en ambos grupos experimentales aumentó y no fue diferente estadísticamente. En el estudio de irritabilidad, se observó una ligera irritación en la mucosa de los biomodelos. Esto no les impidió alimentarse adecuadamente y se observó un incremento del peso corporal de ambos grupos experimentales. Se determinó que las tabletas producen una irritabilidad “leve” de la mucosa oral y no clasifican como tóxicas según las normas internacionales de referencia.

Estabilidad en estante de tabletas de las hojas de Tamarindus indica L / Storage condition stability of Tamarindus indica L leaf tablets

Objetivo: evaluar la estabilidad física, química y microbiológica, en estante, de tabletas de hojas de Tamarindus indica L. Métodos: se evaluaron las propiedades físico-mecánicas, la concentración de polifenoles, los perfiles de disolución y la calidad microbiológica durante dos años, manteniendo las tabletas envasadas en frascos de cloruro de polivinilo de alta densidad, con tapa inviolable y almacenadas en lugar seco y fresco. Se realizaron determinaciones de cada una de las propiedades cada tres meses. Resultados: Durante el estudio, las tabletas mantuvieron el color marrón claro que las caracteriza, el mismo olor fresco a fruta madura y la misma apariencia física. Las propiedades físicas se mantuvieron intactas durante dos años: dureza mayor que 5 kg/f (Monsanto), friabilidad menor que 1 por ciento, masa y la altura dentro de la variabilidad permitida. El tiempo de desintegración fue menor que 10 min. La cantidad de polifenoles liberada en 30 min estuvo por encima del 87 por ciento durante el estudio. Conclusiones: se demostró que las tabletas de tamarindo 120 mg, mantienen las propiedades físico-mecánicas, la concentración de polifenoles y la calidad microbiológica y biofarmacéutica durante dos años. Para asegurar la estabilidad química de las tabletas con mayor precisión, en este momento se desarrollan estudios por cromatografía de capa delgada

Objective: to evaluate the physical stability, chemical and microbiological stability of the Tamarindus indica L tablets on shelf. Methods: the physical and mechanical properties, the polyphenol concentrations, the dissolution profiles and the microbiological quality were evaluated for two years. Tablets were packed in high density PVP flasks and were stored in a dry and fresh place. Each of the properties was determined every three months. Results: throughout the study, the tablets kept their characteristic light brown color, the same odour resembling ripe fruit and the same physical appearance. The physical properties remained unchanged during two years: hardness was higher than 5 kg/f (Monsanto), friability lower than 1 percent, mass and height were within the allowable variability. Disintegration time was less than 10min. The released percentage of polyphenols in 30 min was over 87 percent in the course of study. Conclusions: it was demonstrated that 120mg Tamarind tablets can keep their physical-mechanical properties, the polyphenol concentrations and the microbiological and biopharmaceutical quality for 2 years. Thin layer chromatographic studies are currently conducted to assure more precisely the chemical stability of the tablets

Formulación de comprimidos de tamarindo por el método de granulación húmeda / Formulation of tamarind tablets using the wet granulation method

El objetivo de este trabajo fue la formulación de tabletas farmacéuticas para lo cual se empleó como principio activo el extracto blando de las hojas de la especie Tamarindus indica L. Se utilizó el método de elaboración de tabletas por granulación húmeda a escala de laboratorio. Se prepararon 3 formulaciones en las que se varió las cantidades de lactosa, Aerosil®, celulosa microcristalina y croscarmelosa sódica. Se obtuvieron 3 formulaciones con características adecuadas para el proceso de producción de tabletas, de las cuales la número 3 fue la que mostró mejor calidad tecnológica. Se encontró una relación directa entre la cantidad de desintegrante añadido y el tiempo de desintegración, por lo que deberá estudiarse el efecto de este excipiente para la optimización de esta formulación

The objective of this paper was to prepare tablets using Tamarindus indica L. leaf soft extract as active ingredient. The classic method for manufacturing tablets by means of wet granulation at lab scale was used. Three formulations were prepared in which the quantities of excipients lactose, Aerosil®, microcrystalline cellulose and croscarmellose sodium varied. Three formulations were obtained with adequate characteristics in the manufacturing process but the number 3 exhibited the best technological quality. For further optimization of this formulation, the effect of the excipient must be studied because there was direct relationship between the added amount of disintegrant and the disintegration time

Preformulación de tabletas de Tamarindus indica L. / Preformulation of tablets from Tamarindus indica L.

Se realizó un estudio de preformulación de tabletas partiendo del extracto blando de las hojas de la especie Tamarindus indica L. Se estudiaron posibles interacciones en mezclas binarias del extracto blando con los excipientes en relación 1:3 que puedan afectar la cantidad de polifenoles en la mezcla a temperaturas 30, 45 y 60 ºC. Se diseñaron 3 formulaciones preliminares de tabletas y se estudió en todos los casos la calidad de los granulados y de las tabletas. En conclusión, no se producen interacciones que afecten el color, el olor ni la concentración de polifenoles en las mezclas binarias extracto blando de tamarindo-excipientes a 30 ºC, y a temperaturas mayores se reduce la cantidad de polifenoles en las mezclas. La formulación preliminar número tres produce tabletas de calidad tecnológica y resulta adecuada para los subsecuentes estudios de formulación y optimización de tabletas de tamarindo.

A pre-formulation study for tablet preparation using soft extract from Tamarindus indica L. leaves was conducted. Possible interactions in binary mixtures of Tamarindus indica L. soft extract and selected excipients in a 1:3 ratio, which may affect the amount of polyphenols in the mixture at 30°, 45° and 60 °C temperatures, were analyzed. Three preliminary tablet formulations were designed and then the quality of granules and tables were researched in all the cases. It was concluded that there were no interactions affecting the color, the smell and the polyphenol concentration in the evaluated binary mixtures at 30°. At higher temperatures, the amount of polyphenols decreased. Pre-formulation number 3 yielded the best technological quality in tablet production and thus can be used for future formulation and optimization studies of Tamarind tables.